Fig. 1

Intramuscular treatment approach according to the different schemes. (a) and (b) (Scheme 1): three AWB administrations at five-day intervals and (c) (Scheme 2): single AWB administration. Control groups: administration of SAL, bled and untreated mice, and groups of non-bled and untreated mice